HLA-DR/DQ eplet mismatch predicts de novo donor-specific antibody development in multi-ethnic Southeast Asian kidney transplant recipients on different immunosuppression regimens

被引:1
|
作者
Wong, Emmett Tsz Yeung [1 ,2 ,3 ]
Pochinco, Denise [4 ]
Vathsala, Anantharaman [1 ,2 ]
Koh, Wee Kun [2 ]
Lim, Amy [2 ]
Sran, Hersharan Kaur [1 ,2 ]
D'Costa, Matthew Ross [2 ]
Chang, Zi Yun [2 ]
Nickerson, Peter W. [3 ,4 ,5 ]
Wiebe, Chris [3 ,4 ,5 ]
机构
[1] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore, Singapore
[2] Natl Univ Singapore Hosp, Natl Univ Ctr Organ Transplantat, Singapore, Singapore
[3] Univ Manitoba, Dept Med, Winnipeg, MB, Canada
[4] Shared Hlth Serv Manitoba, Winnipeg, MB, Canada
[5] Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada
关键词
human leukocyte antigen; histocompatibility; molecular mismatch; eplets; kidney transplant; donor-specific antibodies; MEDIATED REJECTION; EPITOPE-MISMATCH; FAILURE; RISK;
D O I
10.3389/fgene.2024.1447141
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Eplet mismatch has been recognized as a more precise strategy for determining HLA compatibility by analyzing donor-recipient HLA differences at the molecular level. However, predicting post-transplant alloimmunity using single-molecule eplet mismatch categories has not been validated in Asian cohorts. We examined a cohort of Southeast Asian kidney transplant recipients (n = 234) to evaluate HLA-DR/DQ eplet mismatch as a predictor of de novo donor-specific antibody (dnDSA) development. HLA-DR/DQ single-molecule eplet mismatch was quantified using HLA Matchmaker, and we utilized previously published HLA-DR/DQ eplet mismatch thresholds to categorize recipients into alloimmune risk groups and evaluate their association with dnDSA development. Recognizing that the predominance of cyclosporine use (71%) may alter published eplet mismatch thresholds derived from a largely tacrolimus-based (87%) cohort, we evaluated cohort-specific thresholds for HLA-DR/DQ single-molecule eplet mismatch categories. Recipient ethnicities included Chinese (65%), Malays (17%), Indians (14%), and others (4%). HLA-DR/DQ dnDSA developed in 29/234 (12%) recipients after a median follow-up of 5.4 years, including against isolated HLA-DR (n = 7), isolated HLA-DQ (n = 11), or both (n = 11). HLA-DR/DQ single-molecule eplet mismatch risk categories correlated with dnDSA-free survival (p = 0.001) with low-risk recipients having a dnDSA prevalence of 1% over 5 years. The cohort-specific alloimmune risk categories improved correlation with HLA-DR/DQ dnDSA-free survival and remained significant after adjusting for calcineurin inhibitor and anti-metabolite immunosuppression (p < 0.001). We validated the performance of single-molecule eplet mismatch categories as a prognostic biomarker for HLA-DR/DQ dnDSA development in a cohort of predominantly Asian kidney transplant recipients after adjusting for different immunosuppression regimens.
引用
收藏
页数:9
相关论文
共 43 条
  • [41] Complement Binding Activity (C3d, C1q) of De Novo Donor-Specific HLA Antibody Is Associated with Increased Risk of Antibody-Mediated Rejection in Non-Sensitized Kidney Transplant Recipients
    Lee, H.
    Han, E.
    Choi, A. -R.
    Park, K.
    Ryu, J.
    Chung, B.
    Yang, C.
    Oh, E. -J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 413 - 413
  • [42] In Kidney Transplant Patients, Alemtuzumab but Not Basiliximab/Low-Dose Rabbit Anti-Thymocyte Globulin Induces B Cell Depletion and Regeneration, Which Associates with a High Incidence of De Novo Donor-Specific Anti-HLA Antibody Development
    Todeschini, Marta
    Cortinovis, Monica
    Perico, Norberto
    Poli, Francesca
    Innocente, Annalisa
    Cavinato, Regiane Aparecida
    Gotti, Eliana
    Ruggenenti, Piero
    Gaspari, Flavio
    Noris, Marina
    Remuzzi, Giuseppe
    Casiraghi, Federica
    JOURNAL OF IMMUNOLOGY, 2013, 191 (05): : 2818 - 2828
  • [43] Solid-Phase C1q/C3d Fixing Readouts Correlate with High Median Fluorescence Intensity (MFI) De Novo Donor-Specific HLA Antibodies and C4d+ Antibody-Mediated Rejection in Kidney Transplant Recipients
    Tatapudi, Vasishta S.
    Kopchaliiska, Dessislava
    da Gente, Gilberto J.
    Buenaventura, Owen F.
    Singh, Manpreet
    Laszik, Zoltan
    Adey, Deborah B.
    Rajalingam, Raja
    ANNALS OF TRANSPLANTATION, 2021, 26